glp 1 drugs meaning Trends in the Development of GLP-1 Receptor Agonists GLP-1 Medications for Weight Loss:

In one of two recently published studies in JAMA Neurology , Allie Seminer , MSc , and Alfredi Mulihano , undergraduate students in the School of Medicine at the University of Galway in Ireland, and colleagues found that GLP-1 receptor agonists significantly reduced the risk for all-cause dementia, but SGLT2 inhibitors did not

and liraglutide (Saxenda, Novo Nordisk)

After observing weight-loss in T2D patients, a once-daily injection of liraglutide (Novo Nordisks Saxenda) was approved for obesity in 2014

Chugai's medicinal chemistry team identified a series of small molecules that could activate the GLP-1 receptor through an unconventional binding mode

Adapted from: Ast J, Novak AN et al

Disclosures Disclosure forms, as provided by each author, are available with the online version of the article at Funding None